BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer and supplier of biomanufacturing tools and services for cell and gene therapy, has reported insider sales, according to its latest SEC filings. Chief Marketing Officer Todd Berard sold 7,508 shares of the company's stock on March 12, 2024. Todd Berard's trades were executed at an average price of $16.64 per share for him, for total sales of approximately $124,893. The insider sales were disclosed through an SEC filing. Over the past year, insiders have sold a total of 15,829 shares of BioLife Solutions Inc., but they did not buy any shares. This latest transaction continues the company's pattern of insider selling, with a total of 109 insider selling and just 4 insider buying over the past year.
BioLife Solutions Inc has a market capitalization of $755,151,000 and the stock traded at $16.64 on the day of recent insider sales. Regarding the company's valuation, BioLife Solutions Inc's Price to GF Value ratio is 0.83, which indicates:. This stock is moderately undervalued based on its GF value of $20.00.
GF Value is GuruFocus' proprietary estimate of intrinsic value that takes into account historical trading multiples, adjustment factors based on a company's past performance, and future performance estimates provided by Morningstar analysts. Masu. Recent selling transactions by insiders may provide some insight for investors. Affects a company's stock valuation and insider sentiment. However, it is important to consider a wide range of factors when evaluating the potential of investing in stocks.
This article created by GuruFocus is intended to provide general insight and is not intended as financial advice. Our commentary is based on historical data and analyst forecasts using an unbiased methodology and is not intended to serve as specific investment guidance. It does not constitute a recommendation to buy or sell stocks, and does not take into account your individual investment objectives or financial situation. Our objective is to provide fundamental data-driven analysis over time. Please note that our analysis may not incorporate the latest announcements or qualitative information from price-sensitive companies. GuruFocus has no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
